| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to restrictions on the substitution of generically |
|
|
equivalent versions of transplant immunosuppresants. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Subchapter A, Chapter 562, Occupations Code, is |
|
|
amended by adding Section 562.0142 to read as follows: |
|
|
Sec. 562.0142. SELECTION OF TRANSPLANT IMMUNOSUPPRESANTS. |
|
|
(a) Except as provided by Subsection (b), a pharmacist may not |
|
|
dispense a drug for immunosuppressive therapy following transplant |
|
|
unless the drug is the specific formulation and manufactured by the |
|
|
specific manufacturer that is prescribed by the patient's |
|
|
physician. |
|
|
(b) A pharmacist may substitute a drug product that is |
|
|
generically equivalent for immunosuppressive therapy following |
|
|
transplant only if, before making the substitution, the pharmacist |
|
|
obtains a signed authorization from the prescribing physician. |
|
|
SECTION 2. This Act takes effect September 1, 2007. |